These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Research and development of donepezil hydrochloride, a new type of acetylcholinesterase inhibitor. Sugimoto H; Ogura H; Arai Y; Limura Y; Yamanishi Y Jpn J Pharmacol; 2002 May; 89(1):7-20. PubMed ID: 12083745 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of novel heterodimers of donepezil and huperzine fragments as acetylcholinesterase inhibitors. Hu Y; Zhang J; Chandrashankra O; Ip FC; Ip NY Bioorg Med Chem; 2013 Feb; 21(3):676-83. PubMed ID: 23273608 [TBL] [Abstract][Full Text] [Related]
10. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids. Bautista-Aguilera OM; Esteban G; Chioua M; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Soriano E; Samadi A; Unzeta M; Marco-Contelles J Drug Des Devel Ther; 2014; 8():1893-910. PubMed ID: 25378907 [TBL] [Abstract][Full Text] [Related]
11. 7-MEOTA-donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies. Korabecny J; Dolezal R; Cabelova P; Horova A; Hruba E; Ricny J; Sedlacek L; Nepovimova E; Spilovska K; Andrs M; Musilek K; Opletalova V; Sepsova V; Ripova D; Kuca K Eur J Med Chem; 2014 Jul; 82():426-38. PubMed ID: 24929293 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and acetylcholinesterase inhibitory activity of huperzine A-E2020 combined compound. Zeng F; Jiang H; Zhai Y; Zhang H; Chen K; Ji R Bioorg Med Chem Lett; 1999 Dec; 9(23):3279-84. PubMed ID: 10612585 [TBL] [Abstract][Full Text] [Related]
13. Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine. Zhao Q; Tang XC Eur J Pharmacol; 2002 Nov; 455(2-3):101-7. PubMed ID: 12445575 [TBL] [Abstract][Full Text] [Related]
14. Tacrine-huperzine A hybrids (huprines): a new class of highly potent and selective acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease. Camps P; Muñoz-Torrero D Mini Rev Med Chem; 2001 Jul; 1(2):163-74. PubMed ID: 12369981 [TBL] [Abstract][Full Text] [Related]
15. Donepezil-tacrine hybrid related derivatives as new dual binding site inhibitors of AChE. Alonso D; Dorronsoro I; Rubio L; Muñoz P; García-Palomero E; Del Monte M; Bidon-Chanal A; Orozco M; Luque FJ; Castro A; Medina M; Martínez A Bioorg Med Chem; 2005 Dec; 13(24):6588-97. PubMed ID: 16230018 [TBL] [Abstract][Full Text] [Related]
16. Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities. Cheng DH; Tang XC Pharmacol Biochem Behav; 1998 Jun; 60(2):377-86. PubMed ID: 9632220 [TBL] [Abstract][Full Text] [Related]
17. Molecular modeling, docking and ADMET studies applied to the design of a novel hybrid for treatment of Alzheimer's disease. da Silva CH; Campo VL; Carvalho I; Taft CA J Mol Graph Model; 2006 Oct; 25(2):169-75. PubMed ID: 16413803 [TBL] [Abstract][Full Text] [Related]
18. New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease. Camps P; El Achab R ; Morral J; Muñoz-Torrero D; Badia A; Baños JE; Vivas NM; Barril X; Orozco M; Luque FJ J Med Chem; 2000 Nov; 43(24):4657-66. PubMed ID: 11101357 [TBL] [Abstract][Full Text] [Related]
19. Recent advances in acetylcholinesterase Inhibitors and Reactivators: an update on the patent literature (2012-2015). McHardy SF; Wang HL; McCowen SV; Valdez MC Expert Opin Ther Pat; 2017 Apr; 27(4):455-476. PubMed ID: 27967267 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation as AChE inhibitors of new indanones and thiaindanones related to donepezil. Omran Z; Cailly T; Lescot E; Santos JS; Agondanou JH; Lisowski V; Fabis F; Godard AM; Stiebing S; Le Flem G; Boulouard M; Dauphin F; Dallemagne P; Rault S Eur J Med Chem; 2005 Dec; 40(12):1222-45. PubMed ID: 16137794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]